Anne‐Marije Hulshof

Author

Anne‐Marije Hulshof

Also Known As

A. M. Hulshof, Anne-Marije Hulshof, Anne-Marije M. Hulshof, Anne‐Marije Hulshof, ir.Y. Henskens

Publications

199

Citations

H-Index

Concepts

All Affiliations

Anne‐Marije Hulshof is an author at Maastricht University Medical Centre specializing in cardiology, medicine, and cardiovascular disease.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	13
2	Pharmacology	1	1	13
3	Hematology	1	1	13
4	Percutaneous Coronary Intervention	1	1	13
5	Cardiology	1	1	13

Anne‐Marije Hulshof

Publications

108

Citations

H-Index

Page 1

	Year	Citations
Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation Anne‐Marije Hulshof, Renée A. G. Brüggemann, Mark M. G. Mulder, Frontiers in Cardiovascular Medicine	2021	50
Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability Tom W. van de Berg, Anne‐Marije Hulshof, Magdolna Nagy, Thrombosis Research	2021	24
Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge Anne‐Marije Hulshof, Dionne C.W. Braeken, Chahinda Ghossein‐Doha, Research and Practice in Thrombosis and Haemostasis	2021	21
The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy Anne‐Marije Hulshof, Minka J. A. Vries, Paul Verhezen, Platelets Inhibitor PercentageAdp Assay ResultsProstaglandin E1PharmacotherapyMultiplate Adp Assay	2020	13

Page 1